Intuitive Surgical (ISRG) Cash from Financing Activities (2009 - 2026)
Intuitive Surgical (ISRG) recorded quarterly Cash from Financing Activities of -$1.4 billion in Q1 2026, down 884.51% quarter-over-quarter from -$137.5 million in Q4 2025, and down 474.09% on a YoY basis from $361.9 million in Q1 2025.
Intuitive Surgical (ISRG) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Intuitive Surgical's Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$1.4 billion for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 474.09% year-over-year to -$1.4 billion; the TTM figure through Mar 2026 stood at -$3.5 billion (down 9015.18% YoY), while the FY2025 annual figure was -$2.4 billion, down 1666.67% from the prior year.
- Cash from Financing Activities was -$1.4 billion for Q1 2026 at Intuitive Surgical, down from -$137.5 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $98.2 million in Q3 2024 to a low of -$1.8 billion in Q3 2025.
- Historically, Cash from Financing Activities has averaged -$378.0 million across 5 years, with a median of -$147.8 million in 2025.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities sank 5280.11% in 2022, then surged 256.83% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at -$963.5 million in 2022, then jumped by 96.73% to -$31.5 million in 2023, then soared by 256.83% to $49.4 million in 2024, then sank by 378.34% to -$137.5 million in 2025, then plunged by 884.51% to -$1.4 billion in 2026.
- The last three Cash from Financing Activities figures came in at -$1.4 billion (Q1 2026), -$137.5 million (Q4 2025), and -$1.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | -230.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.35 Bn |
| Mar 31, 2026 | -1.35 Bn |
| Dec 31, 2025 | -137.50 Mn |
| Dec 31, 2025 | -137.50 Mn |
| Sep 30, 2025 | -1.84 Bn |
| Sep 30, 2025 | -1.84 Bn |
| Jun 30, 2025 | -147.80 Mn |
| Jun 30, 2025 | -147.80 Mn |
| Mar 31, 2025 | -235.80 Mn |
| Mar 31, 2025 | -235.80 Mn |
| Dec 31, 2024 | 49.40 Mn |
| Dec 31, 2024 | 49.40 Mn |
| Sep 30, 2024 | 98.20 Mn |
| Sep 30, 2024 | 98.20 Mn |
| Jun 30, 2024 | 50.00 Mn |
| Jun 30, 2024 | 50.00 Mn |
| Mar 31, 2024 | -46.70 Mn |
| Mar 31, 2024 | -46.70 Mn |
| Dec 31, 2023 | -31.50 Mn |
| Dec 31, 2023 | -31.50 Mn |